Total serum cholesterol levels and Alzheimer's dementia in patients with Down syndrome
- PMID: 18395888
- DOI: 10.1002/gps.2014
Total serum cholesterol levels and Alzheimer's dementia in patients with Down syndrome
Abstract
Background: The risk for dementia in Alzheimer's disease (DAD) in adults with Down syndrome (DS) is higher than in the general adult population. Hypercholesterolaemia has been reported as a risk factor for DAD in the general population. This study investigated the role of serum cholesterol levels in the onset of DAD in the DS population.
Methods: This study investigated total serum cholesterol levels in 179 DS persons (with and without DAD). The possible association between Apolipoprotein E and amyloid beta1-40 and beta1-42 levels was also investigated.
Results: No statistically significant association was found between total serum cholesterol levels and dementia in AD or with amyloid beta levels. However for DS adults with an apoE epsilon4 allele significantly higher serum cholesterol levels were found.
Conclusion: Hypercholesterolaemia is not a risk factor for DAD in persons with DS. However, DS persons with an apoE epsilon4 allele are susceptible to high serum cholesterol. Such individuals should be screened on a regular basis.
Similar articles
-
Increased amyloid beta protein levels in children and adolescents with Down syndrome.J Neurol Sci. 2007 Mar 15;254(1-2):22-7. doi: 10.1016/j.jns.2006.12.010. Epub 2007 Feb 2. J Neurol Sci. 2007. PMID: 17275850
-
Amyloid beta concentrations in older people with Down syndrome and dementia.Neurosci Lett. 2009 Feb 20;451(2):162-4. doi: 10.1016/j.neulet.2008.12.030. Epub 2008 Dec 24. Neurosci Lett. 2009. PMID: 19111900
-
Increased serum neopterin levels in adults with Down syndrome.J Neuroimmunol. 2005 Jul;164(1-2):129-33. doi: 10.1016/j.jneuroim.2005.03.010. J Neuroimmunol. 2005. PMID: 15908015
-
Down syndrome, Alzheimer's disease and seizures.Brain Dev. 2005 Jun;27(4):246-52. doi: 10.1016/j.braindev.2004.07.008. Brain Dev. 2005. PMID: 15862185 Review.
-
Lipid metabolism in cognitive decline and dementia.Brain Res Rev. 2006 Aug;51(2):275-92. doi: 10.1016/j.brainresrev.2005.11.007. Epub 2006 Jan 10. Brain Res Rev. 2006. PMID: 16410024 Review.
Cited by
-
The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer's Disease.J Clin Med. 2021 Oct 3;10(19):4582. doi: 10.3390/jcm10194582. J Clin Med. 2021. PMID: 34640600 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous